F22L (p.Phe22Leu) variant of DRD2 (D(2) dopamine receptor)

F22L (p.Phe22Leu) in DRD2 (D(2) dopamine receptor) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.17 / 1. The record also includes population frequency data and structural context.

F22L (p.Phe22Leu) variant details